We report here that loss of CCBE1 expression is a common event in ovarian cancer, is associated with poor patient outcome and that its loss enhances cancer cell migration and survival, which together suggest that CCBE1 is a new candidate TSG. This evidence concerns the gene CCBE1 and cancer.